Moreover, as stated by Yang et al.,78 higher IL-6, CRP, and procalcitonin levels were observed in patients with both COVID-19 and hypertension, indicating a stronger systemic inflammatory response, which may affect liver metabolism, eventually leading to secondary liver injury. This evidence concerns the gene IL6 and COVID-19.